Resurgent Financial Advisors LLC Astrazeneca PLC Transaction History

Resurgent Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $33,358 - $37,341	539 Added 75.92%	1,249 $84,000
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $9,403 - $10,396	-145 Reduced 16.96%	710 $48,000
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $32,647 - $35,403	-467 Reduced 35.33%	855 $61,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $44,331 - $50,263	-702 Reduced 34.68%	1,322 $91,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $109,721 - $142,570	2,024 New	2,024 $137,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resurgent Financial Advisors LLC with notifications on news.